Rheumatology

ATLANTA — Results of a double-blind, randomized, placebo-controlled trial showed a clear benefit of tofacitinib in controlling disease flares in juvenile idiopathic arthritis, according to a speaker at ACR/ARP 2019.

ATLANTA — Limited knowledge about inactivated vaccines, misconceptions and fears, as well as long wait times and accessibility issues are among the leading drivers of influenza vaccine hesitancy among adults with rheumatoid arthritis and juvenile idiopathic arthritis, according to a presenter at ACR/ARP 2019.

ATLANTA — Approximately 47% of patients in clinical remission after receiving 1 year of weekly tocilizumab for giant cell arteritis maintained their treatment-free remission for an additional 2 years, according to a speaker at the 2019 ACR/ARP Annual Meeting.

ATLANTA — Increased use of glucocorticoid-sparing agents is one of the key recommendations in a guideline document that covers seven vasculitis diseases, according to a speaker at ACR/ARP 2019.

ATLANTA — Because social media guidelines at the institution, practice setting and professional organizations are often vague or open to interpretation, Jilaine Bolek Berquist, MD, a rheumatologist with Mercy Health in Janesville, Wisconsin, focused her “Tweets & Trolls” talk on recommendations for physicians when using social media.

ATLANTA — Exercise is the one nonpharmacological intervention for which there is a strong recommendation in hip, knee, and hand osteoarthritis, according to a guideline update presented at ACR/ARP 2019.

ATLANTA — Among mothers with anti-Ro antibodies who had previously delivered a baby with congenital heart block, hydroxychloroquine was associated with a 50% in risk of that complication in subsequent pregnancies, according to a speaker at ACR/ARP 2019.

ATLANTA — The 2019 iteration of the ACR/ARP Great Debate tackled the issue of whether anabolic therapies are appropriate for patients with glucocorticoid-induced osteoporosis.

ATLANTA — Age at onset of psoriasis determines whether psoriasis or psoriatic arthritis starts first in patients with psoriatic arthritis, according to data from the PsART-international web-based registry presented here.

ATLANTA — The incidence of opioid-related hospitalizations among patients with musculoskeletal conditions increased markedly over the past 2 decades, with continued growth among patients with osteoarthritis, rheumatoid arthritis and fibromyalgia, according to a presentation at the 2019 ACR/ARP Annual Meeting.